Results 221 to 230 of about 495,730 (356)

Antibacterial Applications of Black and Violet Phosphorus‐Based Biomaterials

Advanced NanoBiomed Research, EarlyView.
Black and violet phosphorus‐based biomaterials exhibit broad‐spectrum antibacterial efficacy in various infections, including bone, skin, ocular, dental, lung, and sepsis cases. Their antibacterial mechanisms include physical disruption, light‐driven effects, targeted drug delivery, and enhanced composite strategies.
Zhuo Dai, Yu Zhang, Xiaoye Li, Ao He, Qiang Li, Weijun Xiu, Yongbin Mou, Heng Dong, Meng Ding   +8 more
wiley   +1 more source

Non-O157 Shiga Toxin-Producing Escherichia coli Infections in Europe

Emerging Infectious Diseases, 1997
Alfredo Caprioli, Alberto E. Tozzi, Gianfranco Rizzoni, Helge Karch   +3 more
doaj   +1 more source

Advances and mechanisms of traditional Chinese medicine and its active ingredients against antibiotic-resistant Escherichia coli infections. [PDF]

J Pharm Anal
Yang S, Su P, Li L, Liu S, Wang Y.
europepmc   +1 more source

A ten-year review of ESBL and non-ESBL Escherichia coli bloodstream infections among children at a tertiary referral hospital in South Africa

, 2019
Oliver Ombeva Malande, James Nuttall, Vashini Pillay, Colleen Bamford, Brian Eley   +4 more
openalex   +2 more sources

Chromosome replication as a measure of bacterial growth rate during Escherichia coli infection in the mouse peritonitis model [PDF]

, 2018
Maria Schei Haugan, Godefroid Charbon, Niels Frimodt‐Møller, Anders Løbner‐Olesen   +3 more
openalex   +1 more source

Engineering Tertiary Lymphoid Structures: Nanomedicine, Bioengineering, and Biomaterials for Precision Immunotherapy

Advanced NanoBiomed Research, EarlyView.
This review explains how biomaterials and nanoparticles can be used to induce or modulate tertiary lymphoid structures (TLSs), which are ectopic immune hubs that form in nonlymphoid tissues during chronic disease and cancer. By comparing different methods, the article highlights design principles for modeling TLSs or recapitulating specific TLS ...
Shaza Karaman, Mei ElGindi, Jeremy Teo
wiley   +1 more source

Ruminant-dense environments increase risk of reported Shiga toxin-producing <i>Escherichia coli</i> infections independently of ruminant contact. [PDF]

Appl Environ Microbiol
Ward C, Finical W, Smith K, Rounds JM, Klumb CA, Tarr GAM.   +5 more
europepmc   +1 more source

Case-management protocol for bloody diarrhea as a model to reduce the clinical impact of Shiga toxin-producing Escherichia coli infections. Experience from Southern Italy. [PDF]

Eur J Clin Microbiol Infect Dis, 2020
Loconsole D, Giordano M, Laforgia N, Torres D, Santangelo L, Carbone V, Parisi A, Quarto M, Scavia G, Chironna M, Bloody Diarrhea Apulia Working Group.   +10 more
europepmc   +1 more source

Escherichia coli O157:H7 infections.

The Western journal of medicine, 1994
The Council on Scientific Affairs of the California Medical Association presents the following epitomes of progress in preventive medicine and public health. Each item, in the judgment of a panel of knowledgeable physicians, has recently become reasonably firmly established, both as to scientific fact and clinical importance. The items are presented in
openaire   +1 more source

Cost of Illness and Disease Burden in The Netherlands Due to Infections with Shiga Toxin-Producing Escherichia coli O157

, 2011
Luqman Tariq, Juanita Haagsma, Arie H. Havelaar   +2 more
openalex   +2 more sources